Lung-MAP (Lung Cancer Master Protocol) (SWOG S1400)

Targeted Disease(s):
Lung Cancer

Purpose of Study:

Squamous cell lung cancer. Lung-MAP is a multi-arm trial designed to test several different therapies simultaneously. MEDI4736, GDC-0032, Palbociclib, and AZD4547 are currently being studied, but the trial protocol could allow new therapies to be added in the future.

Study Dates:
June 16, 2014 - January 1, 2022

Study Location:
Nationwide

Register for Trial

No upcoming events near you